Fitzgerald Meghan sold (to issuer) $86K of THC
Fitzgerald Meghan sold (to issuer) 493 shares of TENET HEALTHCARE CORP (THC) at $173.78 on 2026-05-22.
How this was made
The 30-second read
Why it matters
The disclosure provides transparency on insider ownership but does not include operational, regulatory, or financial catalysts.
Market read
Traders may briefly reassess insider alignment, but the transaction type (sale to issuer) suggests limited fundamental signal.
What to watch
No 10b5-1 plan is listed, so traders may scrutinize whether the sale was discretionary; also, the issuer’s buyback mechanics could affect float and liquidity.
Background
The article is an SEC Form 4 insider transaction disclosure for Tenet Healthcare director Fitzgerald Meghan.
Ticker impact
Tenet Healthcare director Fitzgerald Meghan sold 493 shares to the issuer for about $85.7K at $173.78/share, per SEC Form 4.
Limited near-term impact; any reaction is likely noise unless repeated or paired with other negative disclosures.
The filing specifies code D (sale to issuer) and notes no 10b5-1 plan; however, the transaction type is typically mechanical and not tied to new fundamentals.
Market effects
Minimal; single insider transaction in a healthcare services name does not reset sector expectations.
None indicated.
None indicated.
Counterpoint
If the director’s sale is part of a broader pattern of trimming, it could slightly increase perceived overhang despite the code D classification.
Key entities
- issuerTenet Healthcare Corp
Subject of the SEC Form 4 insider transaction; director sold shares to the issuer (code D).
- insiderFitzgerald Meghan
Director who sold 493 shares to the issuer at $173.7800/share.
